Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DTI-0009: Began Phase II trial

Discovery Therapeutics Inc., Richmond, Va.
Product: DTI-0009

Read the full 74 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE